GLAUKOS Corp Fair Value Disclosure
Note 4. Fair Value Measurements
The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2025 and December 31, 2024, and indicate the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value (in thousands):
|
|
At December 31, 2025 |
|
|||||||||||||
|
|
|
|
|
|
|
|
Significant |
|
|
|
|
||||
|
|
|
|
|
Quoted prices in |
|
|
other |
|
|
Significant |
|
||||
|
|
|
|
|
active markets for |
|
|
observable |
|
|
unobservable |
|
||||
|
|
December 31, |
|
|
identical assets |
|
|
inputs |
|
|
inputs |
|
||||
|
|
2025 |
|
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
||||
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Money market funds (i) |
|
$ |
28,301 |
|
|
$ |
28,301 |
|
|
$ |
— |
|
|
$ |
— |
|
Available for sale securities: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
U.S. treasury securities (ii) |
|
|
67,170 |
|
|
|
— |
|
|
|
67,170 |
|
|
|
— |
|
Commercial paper (ii) |
|
|
10,813 |
|
|
|
— |
|
|
|
10,813 |
|
|
|
|
|
Bank certificates of deposit (ii) |
|
|
61,006 |
|
|
|
— |
|
|
|
61,006 |
|
|
|
— |
|
Corporate notes (ii) |
|
|
36,110 |
|
|
|
— |
|
|
|
36,110 |
|
|
|
— |
|
Asset-backed securities (ii) |
|
|
10,623 |
|
|
|
— |
|
|
|
10,623 |
|
|
|
— |
|
Municipal bonds (ii) |
|
|
2,225 |
|
|
|
— |
|
|
|
2,225 |
|
|
|
— |
|
Investments held for deferred compensation plans (iii) |
|
|
19,541 |
|
|
|
— |
|
|
|
19,541 |
|
|
|
— |
|
Total Assets |
|
$ |
235,789 |
|
|
$ |
28,301 |
|
|
$ |
207,488 |
|
|
$ |
— |
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Deferred compensation plans (iv) |
|
$ |
18,493 |
|
|
$ |
— |
|
|
$ |
18,493 |
|
|
$ |
— |
|
Contingent consideration (v) |
|
|
9,265 |
|
|
|
— |
|
|
|
— |
|
|
|
9,265 |
|
Total Liabilities |
|
$ |
27,758 |
|
|
$ |
— |
|
|
$ |
18,493 |
|
|
$ |
9,265 |
|
|
|
At December 31, 2024 |
|
|||||||||||||
|
|
|
|
|
|
|
|
Significant |
|
|
|
|
||||
|
|
|
|
|
Quoted prices in |
|
|
other |
|
|
Significant |
|
||||
|
|
|
|
|
active markets for |
|
|
observable |
|
|
unobservable |
|
||||
|
|
December 31, |
|
|
identical assets |
|
|
inputs |
|
|
inputs |
|
||||
|
|
2024 |
|
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
||||
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Money market funds (i) |
|
$ |
69,854 |
|
|
$ |
69,854 |
|
|
$ |
— |
|
|
$ |
— |
|
Available for sale securities: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
U.S. treasury securities (ii) |
|
|
115,891 |
|
|
|
— |
|
|
|
115,891 |
|
|
|
— |
|
Bank certificates of deposit (ii) |
|
|
5,623 |
|
|
|
— |
|
|
|
5,623 |
|
|
|
— |
|
Corporate notes (ii) |
|
|
16,938 |
|
|
|
— |
|
|
|
16,938 |
|
|
|
— |
|
Asset-backed securities (ii) |
|
|
7,819 |
|
|
|
— |
|
|
|
7,819 |
|
|
|
— |
|
Municipal bonds (ii) |
|
|
3,018 |
|
|
|
— |
|
|
|
3,018 |
|
|
|
— |
|
Investments held for deferred compensation plans (iii) |
|
|
14,741 |
|
|
|
— |
|
|
|
14,741 |
|
|
|
— |
|
Total Assets |
|
|
233,884 |
|
|
|
69,854 |
|
|
|
164,030 |
|
|
|
— |
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Deferred compensation plans (iv) |
|
$ |
14,640 |
|
|
$ |
— |
|
|
$ |
14,640 |
|
|
$ |
— |
|
Contingent consideration (iv) |
|
|
1,585 |
|
|
|
— |
|
|
|
— |
|
|
|
1,585 |
|
Total Liabilities |
|
|
16,225 |
|
|
|
— |
|
|
|
14,640 |
|
|
|
1,585 |
|
Money market funds are highly liquid investments and are actively traded. The pricing information on these investment instruments is readily available and can be independently validated as of the measurement date. This approach results in the classification of these securities as Level 1 of the fair value hierarchy.
U.S. government agency bonds, U.S. treasury securities, bank certificates of deposit, commercial paper, municipal bonds, corporate notes and asset-backed securities are measured at fair value using Level 2 inputs. The Company reviews trading activity and pricing for these investments as of each measurement date. Pursuant to the Company’s deferred compensation plan (the Deferred Compensation Plan), the Company has also established a rabbi trust that serves as an investment to shadow the Deferred Compensation Plan liability. The investments of the rabbi trust and Deferred Compensation Plan liability consist of company-owned life insurance policies (COLIs) and the pricing on these investments can be independently evaluated. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from third party data providers. These inputs represent quoted prices for similar assets in active markets or these inputs have been derived from observable market data. This approach results in the classification of these securities as Level 2 of the fair value hierarchy.
The Company’s acquisitions may include contingent consideration as part of the purchase price. The fair value of the contingent consideration is estimated as of the acquisition date based on significant inputs not observable in the market, which include the present value of the contingent payments to be made using a Monte Carlo simulation model, computation of net sales volatility, discount rates derived using internal rate of return analysis, the probability and timing of achieving certain future milestones, and to a lesser extent, Glaukos’ credit rating. Contingent consideration represents a Level 3 measurement within the fair value hierarchy. The valuation of contingent consideration uses assumptions the Company believes a market participant would make. The Company assesses these estimates on an ongoing basis as it obtains additional data impacting the assumptions. Should actual
results increase or decrease as compared to the assumptions used in the analysis, the fair value of the contingent consideration obligations will increase or decrease, up to the contracted limit, as applicable. Any changes in the fair value of contingent consideration related to updated assumptions and estimates are recognized within other income (expense), net in the consolidated statements of operations.
As of December 31, 2025 and December 31, 2024, the Company's contingent consideration liability was $9.3 million and $1.6 million, respectively. As of December 31, 2025, the balance included the contingent consideration liability related to the Mobius Agreement, with a roll forward of activity for the year ended December 31, 2025 as follows:
|
|
Year ended |
|
|
|
|
December 31, |
|
|
|
|
2025 |
|
|
Balance at January 1, 2025 |
|
$ |
1,585 |
|
Additions |
|
|
7,700 |
|
|
|
(20 |
) |
|
Balance at December 31, 2025 |
|
$ |
9,265 |
|
There were no transfers between levels within the fair value hierarchy during the periods presented.
The Company did not have any assets or liabilities measured at fair value on a recurring basis within Level 3 fair value measurements as of December 31, 2024.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 23, 2026 | Showing above |
| 2024 | Feb 25, 2025 | |
| 2023 | Feb 23, 2024 | |
| 2022 | Feb 24, 2023 | |
| 2021 | Feb 28, 2022 | |
| 2020 | Mar 1, 2021 | |
| 2019 | Mar 2, 2020 | |
| 2018 | Feb 28, 2019 | |
| 2017 | Feb 28, 2018 | |
| 2016 | Mar 15, 2017 | |
| 2015 | Mar 15, 2016 | |
About Fair Value Disclosures
Fair value disclosures classify all assets and liabilities measured at fair value into a three-level hierarchy: Level 1 (quoted market prices), Level 2 (observable inputs like yield curves), and Level 3 (unobservable inputs requiring management estimates). The proportion of Level 3 assets directly reflects how much of the balance sheet depends on internal models rather than market evidence.
Key signals: a growing Level 3 balance relative to total fair-value assets increases valuation uncertainty and earnings volatility risk. Watch for transfers between levels — assets moving from Level 2 to Level 3 often signal deteriorating market liquidity. Unrealized gains and losses on Level 3 positions flow through earnings or other comprehensive income, so large swings deserve scrutiny. For financial institutions, examine the sensitivity disclosures that show how Level 3 valuations change under alternative assumptions. Compare the fair value of debt against its carrying amount to gauge hidden leverage.